Download the notification: The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of Nineteen (19) formulations under the Drugs (Prices Control) Order, 2013, vide notification S.O. 796(E) dated 18-02-2022.

Click here to download the notification S.O. 796E) dated 18-02-2022

NPPA, in its order on February, 18, listed the Ninteen (19) formulations for which it has fixed retail prices. A list of the formulations has been given below:

Click for more articles on NPPA

Formulations:

Sl. No.Name of the Formulation/ Brand NameStrengthUnitManufacturer & Marketing CompanyRetail Price (Rs.)(1)(2)(3)(4)(5)(6)1.    Paracetamol + Phenylephrine + Caffeine+ Diphenhydramine TabletEach film coated tablet contains: Paracetamol IP 500 mg + Phenylephrine Hydrochloride IP 5 mg + Caffeine (anhydrous) 30 mg + Diphenhydramine Hydrochloride IP 25 mg        1 Tablet    M/s. Mediforce Healthcare Pvt. Ltd./ M/s. Mankind Prime Labs Pvt. Ltd.3.212.    Gliclazide ER + Metformin ER TabletEach uncoated bilayered tablet contains: Gliclazide IP (as extended release form) 60mg Metformin Hydrochloride IP (As extended release form) 1000mg      1 Tablet  M/s. Ravenbhel Healthcare Pvt. Ltd. / M/s. Eris Lifesciences Limited8.543.  Chlorthalidone + Telmisartan + Amlodipine TabletEach film coated tablet contains: Chlorthalidone IP 6.25mg Telmisartan IP 40mg Amlodipine Besilate IP eq. to Amlodipine 5mg    1 Tablet  M/s. Swiss Garnier Genexiaa Sciences / M/s. USV Pvt. Ltd.8.92

4.  Telmisartan + Cilnidipine TabletEach film coated bilayered tablet contains: Telmisartan IP 40mg Cilnidipine IP 10mg  1 TabletM/s. Windlas Biotech Pvt. Ltd. / M/s. USV Pvt. Ltd.9.665.  Gliclazide + Metformin Hydrochloride (Sustained release) TabletEach uncoated bilayered sustained release tablet contains: Gliclazide IP 60 mg Metformin Hydrochloride IP 1000 mg    1 Tablet  M/s. Windlas Biotech Pvt. Ltd. / Panacea Biotec Pharma Ltd8.546.        Atorvastatin & Clopidogrel CapsuleEach hard Gelatin Capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 20mg (As two Film Coated Tablets Each containing Atorvastatin 10mg) Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As two film coated tablets Each containing 37.5 mg Clopidogrel)          1 Capsule        M/s. Windlas Biotech Limited / M/s. Torrent Pharmaceuticals Limited16.707.    Telmisartan, Cilnidipine & Metoprolol (ER) TabletsEach film coated bilayered tablet contains: Telmisartan IP 40mg Cilnidipine IP 10mg Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate (as extended release) 25mg      1 Tablet    M/s. Ravenbhel Healthcare Pvt. Ltd./ M/s. Alkem Laboratories Limited10.688.    Telmisartan, Cilnidipine & Metoprolol (ER) TabletsEach film coated bilayered tablet contains: Telmisartan IP 40mg Cilnidipine IP 10mg Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate (as extended release) 50mg      1 Tablet    M/s. Ravenbhel Healthcare Pvt. Ltd./ M/s. Alkem Laboratories Limited12.959.    Metformin + Glimepiride TabletEach Uncoated bilayered tablet contains: Metformin Hydrochloride IP 500mg (as Prolonged- Release) Glimepiride IP 2mg    1 Tablet  M/s. Associated Biotech / M/s. Dales Laboratories7.5910.        Atorvastatin & Clopidogrel CapsuleEach hard Gelatin Capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 10mg (As Film Coated Tablet) Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As two film coated tablets) Each containing 37.5 mg Clopidogrel        1 Capsule      M/s. Windlas Biotech Limited / M/s. Torrent Pharmaceuticals Limited12.55

11.  Diclofenac TabletEach film coated prolonged release tablet contains: Diclofenac Sodium IP 100mg  1 TabletM/s. Pure and Cure Healthcare Pvt. Ltd. / M/s. Alembic Pharmaceuticals Ltd.6.6812.    Metformin + Glimepiride TabletEach Uncoated bilayered tablet contains: Metformin Hydrochloride IP 500mg (as Prolonged- Release) Glimepiride IP 1mg    1 Tablet  M/s. Associated Biotech / M/s. Dales Laboratories6.2513.Telmisartan + Amlodipine + Hydrochlorothiazide TabletEach film coated tablet contains: Telmisartan IP 40 mg + Amlodipine Besilate IP eq. to Amlodipine 5mg + Hydrochlorothiazide IP 12.5 mg      1 Tablet  M/s. Akums Drugs & Pharmaceuticals Ltd. / M/s. Emcure Pharmaceuticlas Ltd.9.7914.Paracetamol + Thiocolchicoside TabletEach uncoated tablet contains: Paracetamol IP 500 mg Thiocolchicoside IP 4 mg  1 Tablet  M/s. Micro Labs Limited16.9415.Pantaprozole Dual- release Gastro-resistant tablet (Aristo Pantop 80)Each Dual-release Gastro- resistant tablet contains: Pantoprazole Sodium IP eq. to Pantoprazole 80 mg  1 TabletM/s. Aristo Pharmaceuticals Pvt. Ltd.14.7416.    Calcium, Vitamin D3, Mecobalamin, L- Methylfolate Calcium & Pyridoxal-5-Phosphate TabletEach film coated tablet contains: Calcium Carbonate IP 1250mg eq. to Elemental Calcium 500mg Vitamin D3 IP 2000IU Mecobalamin IP (Methylcobalamin) 1500mcg L-Methylfolate Calcium 1mg Pyridoxal-5-Phosphate 20mg        1 Tablet      M/s. Akums Drugs & Pharmaceuticals Ltd. / M/s. Mankind Pharma Ltd.15.5517.  Diclofenac Transdermal PatchEach 37.5 Sq cm Transdermal Patch contains: Diclofenac Diethylamine IP 100mg  1 PatchM/s. Azista Industries Pvt. Ltd. / M/s. Hetero Healthcare Ltd.31.2518.    Diclofenac Diethylamine + Methyl Salicylate + Menthol topical SprayComposition: Diclofenac Diethylamine IP 2.32% w/w (Eq. to Diclofenac Sodium 2% w/w) Methyl Salicylate IP 10% w/w Menthol IP 5% w/w      1 Gram    M/s. Pontika Aerotech Limited / M/s. Intas Pharmaceuticals Limited2.9319.  Paracetamol InfusionEach 100ml contains: Paracetamol 1.0% w/v (10mg/ml)  1 MLM/s. Axa Parenterals Limited / M/s. Aristo Pharmaceuticals Pvt. Limited3.05

Click for more articles on DPCO

(a) The manufacturer of above mentioned formulations i.e. ―new drug‖ under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.

(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.

(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

(g) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.

Must read

Latest notifications – DPCO /NPPA

FAQs – On DPCO: Drugs (Prices Control) Order, 2013

NPPA fixes retail price of 2 formulations: December 2021

NPPA fixes retail price of 28 formulations: December 2021

NPPA fixes retail price of 20 formulations: December 2021

NPPA fixes retail price of 2 formulations: November 2021

NPPA fixes retail price of 47 formulations: November 2021

NPPA fixes retail price of 12 Anti Diabetic medicines: October 2021

ICMR to conduct Clinical Trial for new drugs regimen for MDR TB

PCB issues directions to Pharma Companies to comply with norms

Police protection sought for Drugs Control Officers

USFDA gives nod to Lupin for sNDA for Solosec

India reports outbreak of H5N1 Bird Flu Virus

USFDA gives nod to this Molecule to treat retinal vascular diseases

Govt recommends continuation of anti-dumping duty on import of Amoxycillin

Drug recall: Red Mammoth capsules recalled due to this reason

Molnupiravir effective against Omicron, could reduce deaths: Study

Latest Notifications regarding Pharmaceuticals
https://thehealthmaster.com/2022/02/23/nppa-fixes-retail-price-of-19-formulations-february-2022/